• SENSEX 81,366.48
    -84.53 (--0.10%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Niva Bupa Health
    82.00 61.01(%)
  • Reliance Power
    62.80 60.50(%)
  • Max Healthcare
    1,156.95 1,227.50(%)
  • Mazagon Dock
    3,380.35 1,200.00(%)
  • Garden Reach Sh.
    2,875.00 1,148.10(%)
  • Suzlon Energy
    73.44 86.04(%)
  • Yes Bank
    22.86 27.41(%)
  • St Bk of India
    818.50 912.10(%)
  • Eternal Ltd
    243.00 304.50(%)
  • Inox Wind
    188.50 124.35(%)
  • Reliance Infra.
    346.80 350.90(%)
  • Cochin Shipyard
    1,900.55 1,180.45(%)
  • SG Finserve
    445.95 546.00(%)
  • Bharat Dynamics
    1,965.00 897.15(%)
  • Bank of Maha
    57.80 73.50(%)
  • MMTC
    77.42 42.55(%)
  • Reliance Industr
    1,395.90 1,115.55(%)
  • Data Pattern
    2,972.00 3,654.75(%)
  • NBCC
    127.25 139.83(%)
  • Vodafone Idea
    7.10 19.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Raymed Labs Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5975.0
  • ISIN : INE741C01017
3.32 0 (4.73%)
  • As on 02 Jun 2025 (EOD)

  • Today’s Low

    3.32

  • Today’s High

    3.32

  • Open

    3.32

  • Perv Close

    3.17

  • 52W Low

    2.28

  • 52W High

    3.32

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    1.42

  • Div & Yield %

    0.00

  • Book Value(₹)

    -6.07

  • Debt-Equity Ratio

    4.73

  • AGM Date

    12-May-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    1.42

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.27

  • BV (₹)

    -6.10

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -0.18

  • NP Var(%)

    -78.0

  • Div%

    0.0

  • CPS (₹)

    -0.40

  • EPS (₹)

    -0.40

  • Traded Value (₹ in Lakhs)

    1.42

  • 52 Week High

    3.32

  • 52 Week Low

    2.28

  • Price BSE

    3.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    1.42

  • P/C Ratio

    -7.30

  • P/E Ratio

    -7.10

  • Price Vs.BV

    -0.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.00 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.02 0.00 0.01 0.01 0.01
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 0.00 0.02 0.00 0.01 0.01 0.01
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.04 0.04 0.03 0.02 0.02 0.01
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Selling and Administration Expenses 0.06 0.06 0.05 0.05 0.05 0.02
Miscellaneous Expenses 0.00 0.09 0.00 0.00 0.00 0.03
Employee Benefit Expenses 0.04 0.04 0.03 0.02 0.02 0.01
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 0.10 0.19 0.08 0.07 0.06 0.06
Operating Profit -0.10 -0.17 -0.08 -0.06 -0.05 -0.05
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit -0.10 -0.17 -0.08 -0.06 -0.05 -0.05
Depreciation 0.00 0.01 0.01 0.01 0.01 0.01
Profit Before Tax -0.10 -0.18 -0.09 -0.07 -0.06 -0.06
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -0.10 -0.17 -0.08 -0.07 -0.06 -0.05
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 -0.03
Adjusted Net Profit -0.10 -0.17 -0.08 -0.07 -0.06 -0.02
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -6.58 -6.41 -6.33 -6.26 -6.20 -6.15
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -6.68 -6.58 -6.41 -6.33 -6.26 -6.20
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.24 -0.40 -0.19 -0.16 -0.13 -0.13
Earnings Per Share(Adj)-Unit Curr -0.24 -0.40 -0.19 -0.16 -0.13 -0.13
Book Value -5.63 -5.40 -5.00 -4.80 -4.64 -4.51
Book Value(Adj)-Unit Curr -5.63 -5.40 -5.00 -4.80 -4.64 -4.51

Shareholding Pattern

  • Promoter Group

    32.27%

  • Public Share Holding

    67.73%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,379,217 32.27 1,379,217 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,379,217 32.27 1,379,217 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 41,000 0.96 0 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 41,000 0.96 0 1
2] Non Institution
Bodies Corporate 682,952 15.98 660,052 43
Clearing Members 50 0.00 50 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 57,500 1.35 45,300 13
Foreign Non Institution Other 200,000 4.68 0 1
Hindu Undivided Families 35,233 0.82 35,233 13
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 539,624 12.63 495,624 9
Individuals holding nominal share capital up to Rs. 1 lakh 1,337,924 31.31 872,174 1,404
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,853,283 66.77 2,108,433 1,484
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 4,273,500 100.00 3,487,650 1,490

Company Background

Raymed Labs LtdPharmaceuticals - Indian - Formulations

  • Raymed Labs Ltd
  • BSE Code : 5975.0
  • ISIN : INE741C01017

  • Incorporation Year

    1992

  • Registered Office

    103 Emperor 1 Sector 93A
    Supertech Emerald Court, Noida,
    Uttar Pradesh-201304

  • Telephone

    91-0120-2426900/9412700300

  • FAX

  • Chairman

  • Managing Director

    Prashant Nathmal Bajaj

  • Company Secretary

  • Auditor

    A Kay Mehra & Co/KTPS & Co.

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Beetal Fin.& Comp. Ser.(P) Ltd
    Beetal House 99 ,
    Madangir Behind LSC ,Nr Dada Harsukhdar
    Mumbai - Delhi - 110062

Raymed Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Raymed Labs 3.32 0.00 0.00 -7.90 0.00
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92